Net operating revenues reached $2.965 billion, down 6.1% from $3.159 billion in Q1 2025. Net loss attributable to stockholders was $58 million, or $0.43 per diluted share, compared to a $13 million loss in the prior year period. Adjusted EBITDA declined to $309 million from $376 million in Q1 2025. Net cash used in operating activities was $297 million, a significant reversal from $120 million provided in Q1 2025. Same-store admissions decreased 1.3% and adjusted admissions fell 0.5% year-over-year. The company redeemed approximately $223 million in principal amount of its 10.875% Senior Secured Notes due 2032.